The Advisory Council on Alzheimer's Research, Care, and Services meets quarterly to discuss programs that impact people with Alzheimer's disease and related dementias (AD/ADRD) and their caregivers. Representatives from agencies and organizations that work with dementia treatment and care are invited to present information to the Advisory Council. The public is also given time at each meeting to provide first-hand information of their day-to-day experience.
This section provides the information available for each Advisory Council meeting.
Comments and questions, or alerts to broken links, should be sent to napa@hhs.gov.
2026 Meetings
August 3, 2026 — Advisory Council
During the third meeting of 2026, the Advisory Council will hear from a panel organized by the research subcommittee; updates from federal agencies, including an overview of the authorities of the National Institutes of Health, the Food and Drug Administration, and the Centers for Medicare & Medicaid Services; legislative updates from advocacy groups; and an update on the Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease (REMIND) Study. Advisory Council subcommittees will also present their recommendations for adoption by the full Advisory Council.
General Material:
Presentation Slides:
- Opening Remarks – Research Subcommittee Chair
- Biomarkers
- The Convergence of Down Syndrome and Alzheimer’s Disease — Scientific and Ethical Imperatives
- Can We Detect and Treat Alzheimer’s Disease a Decade Before Dementia? (And Why We Must!)
- AI and Alzheimer’s Disease
- C-BRAIN AI-Powered Discovery & Potential Applications
- The Federal Role in Bringing Breakthrough Treatments to Patients
- The BRIDGE Act
- The CHANGE Act
April 27, 2026 — Advisory Council
During the second meeting of 2026, Advisory Council members heard updates from federal agencies on activities during the last quarter and presentations focused on advancements in long-term services and supports and Alzheimer’s disease care. Presenters discussed faith-based and community partnerships in long-term services and support, expanding access to early diagnosis and quality dementia care, the Navigating Aging Needs Navigator Tool, and the Respite for All-faith and community-based care model. The meeting also included a presentation on lessons learned from implementing an innovative service delivery model for people living with Alzheimer’s disease or related dementias and their caregivers.
General Material:
Presentation Slides and Written Updates:
- Federal Agency Updates
- Advancing Early Diagnosis and Dementia Care Through Policy and Advocacy
- Navigating Aging Needs Navigator (NAN) Tool
- Respite for All
- GUIDE Model: Implementation and Early Insights
- Written Updates from Federal Agencies
Videos:
February 9, 2026 — Advisory Council
During the first meeting of 2026, HHS introduced and swore in a new slate of Advisory Council members. Federal agencies provided an overview of their work under the National Alzheimer’s Project Act since 2011, and the Advisory Council discussed a plan for updating the National Plan to Address Alzheimer’s Disease for 2026-2035. The meeting also included presentations on innovative approaches in Alzheimer's disease interventions.
General Material:
Presentation Slides:
- National Alzheimer’s Project Act Overview
- New Federal Agency Partners SSA
- Federal Agency Roles and Progress Part 1: NIH, FDA, NSF, DOW, CMS
- Federal Agency Roles and Progress Part 2: ACL, HRSA, CDC
- Ten Years of Transformative Progress in Alzheimer's Dementia Research: From DIAN Insights to AI-Powered Discovery: Alzheimer’s Prevention, Aging, and Artificial Intelligence
- Federal Agency Roles and Progress Part 3: IHS, AHRQ, SAMHSA, ASPE
- Robotic Surgical Procedure to Address Alzheimer’s
- Approach to Updating National Plan for 2026-2035
Handouts:
Videos: